Search Results:　 1-20 of 1484

Egawa Tatsuro , Masuda Shinya , Goto Katsumasa 他

The journal of physical fitness and sports medicine : JPFSM : official journal of the Japanese Society of Physical Fitness and Sports Medicine 1(4), 709-713, 2012-11-00

TAHARA Atsuo , KUROSAKI Eiji , YOKONO Masanori , YAMAJUKU Daisuke , KIHARA Rumi , HAYASHIZAKI Yuka , TAKASU Toshiyuki , IMAMURA Masakazu , QUN Li , TOMIYAMA Hiroshi , KOBAYASHI Yoshinori , NODA Atsushi , SASAMATA Masao , SHIBASAKI Masayuki

Journal of pharmacological sciences 120(1), 36-44, 2012-09-20

References (29)

LUAN Jiajie , LI Weiping , HAN Jia , ZHANG Wen , GONG Huiling , MA Rong

… The present study was carried out to investigate the protective effects of tempol on renal function and the underlying mechanism in streptozotocin-induced diabetic rats. …

Journal of Pharmacological Sciences 119(2), 167-176, 2012-06-20

J-STAGE CrossRef References (57)

IKEDA Akihiko , MATSUSHITA Shonosuke , SAKAKIBARA Yuzuru

… In the DM and DM+PKC-I groups, diabetes was induced by streptozotocin (STZ) (1.5mg/body i.p.) for 5 days. …

Circulation Journal 76(4), 943-949, 2012-03-25

J-STAGE Ichushi Web CrossRef References (42)

FENG Xiao-Tao , QIN Can-Bin , LENG Jing , TANG Qian-Li , SHI Hong , ZHAI Lin-Na , LI Shuang-Lei

… Moreover, streptozotocin-induced diabetes severely impaired rats' erectile function and the activity of the NO-cGMP pathway in the corpora cavernosum, and treatment with Yidiyin for 4 weeks obviously increased the rats' erectile function, remarkably enhanced the activity of nitric oxide synthase (NOS), and elevated the contents of NO and cGMP. …

Bioscience, Biotechnology, and Biochemistry 76(2), 257-263, 2012-02-23

J-STAGE Ichushi Web CrossRef References (51)

Sekiguchi Yukari , Owada Junya , Oishi Hisashi , Katsumata Tokio , Ikeda Kaori , Kudo Takashi , Takahashi Satoru , 大石 久史 , 工藤 崇 , 高橋 智

… Conversely, there was a strong reduction in the signal observed in diabetic Mafa-deficient/Mafk-transgenic mutant mice and streptozotocin-treated mice, reflecting the loss of β-cells. …

Experimental animals 61(4), 445-451, 2012-00-00

IR CrossRef

Sekiguchi Yukari , Owada Junya , Oishi Hisashi , Katsumata Tokio , Ikeda Kaori , Kudo Takashi , Takahashi Satoru

… Conversely, there was a strong reduction in the signal observed in diabetic Mafa-deficient/Mafk-transgenic mutant mice and streptozotocin-treated mice, reflecting the loss of β-cells. …

Experimental Animals 61(4), 445-451, 2012

J-STAGE CrossRef

Yamada Kumi , Niki Hisae , Nagai Hitoshi , Nishikawa Masakuni , Nakagawa Haruto

… In streptozotocin-induced diabetic rats, polyethylene tube–induced thrombus formation was enhanced compared with that in normal rats. …

Journal of Pharmacological Sciences 119(3), 243-250, 2012

J-STAGE CrossRef

Tahara Atsuo , Kurosaki Eiji , Yokono Masanori , Yamajuku Daisuke , Kihara Rumi , Hayashizaki Yuka , Takasu Toshiyuki , Imamura Masakazu , Qun Li , Tomiyama Hiroshi , Kobayashi Yoshinori , Noda Atsushi , Sasamata Masao , Shibasaki Masayuki

… The present study investigated the antidiabetic effects of ipragliflozin, a SGLT2-selective inhibitor, in streptozotocin–nicotinamide-induced mildly diabetic mice, which exhibited a mild decline in glucose tolerance associated with the loss of early-phase insulin secretion. …

Journal of Pharmacological Sciences 120(1), 36-44, 2012

J-STAGE CrossRef